This document discusses diabetic emergencies including hypoglycemia, diabetic ketoacidosis, and hyperosmolar hyperglycemic state. It describes the causes, symptoms, diagnostic criteria, treatment and prevention of each condition. Hypoglycemia results from low blood sugar and is treated with oral carbohydrates or intravenous dextrose. Diabetic ketoacidosis occurs due to insufficient insulin and is characterized by high blood sugar, ketones and acidosis. Hyperosmolar hyperglycemic state involves severe high blood sugar and dehydration without significant ketoacidosis. Both diabetic ketoacidosis and hyperosmolar hyperglycemic state require intravenous fluids and insulin treatment.
2. Objectives
General Objective:
• Identify the common diabetic complications in an
emergency setting.
Specific Objective:
• Describe diabetic ketoacidosis, hyperosmolar
syndrome, and hypoglycemia.
• Describe their diagnosis, treatment, and prevention.
3. Introduction
• People with diabetes suffer from diabetic
complications that may arise due to erratic blood
sugar levels, missed meals, accidental overdose of
medications, or too much strenuous exercise. These
things could affect the sensitive body of a person
with diabetes and could lead to
serious incidences of hypoglycemia or
hyperglycemia.
4. Introduction
• Uncontrolled blood sugar often contributes to the
incidence of diabetic emergencies and
complications. Individuals who experience blood
sugar levels that are too high or low for prolonged
periods of time may develop conditions that could
lead to a coma.
• Hypoglycemia results from excessively low blood
sugar levels caused by either insufficient food
consumption or the presence of too much insulin.
5. Introduction
• Diabetic ketoacidosis is a condition that occurs due
to an absence or insufficient supply of insulin, which
forces the body to burn fat and creates ketones that
subsequently accumulate in the body.
• Hyperosmolar syndrome is a diabetic condition that
results from excessively high blood sugar levels,
which cause the blood to adopt a thick consistency.
7. • Hypoglycemia or low blood glucose is a
clinical state associated with <55mg/dl or low
plasma glucose with typical symptoms.
The Journal of Clinical
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
8. Whipples triad
ď‚— Symptoms consistent with hypoglycemia
ď‚— Low plasma glucose concentration
ď‚— Relief of those symptoms after the plasma
glucose level is raised
The Journal of Clinical
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
10. Risk factors
ď‚— insulin doses are excessive, ill-timed, or of the wrong
type
ď‚— influx of exogenous glucose ď‚Ż
ď‚— insulin-independent glucose utilization ď‚
ď‚— sensitivity to insulin ď‚
ď‚— endogenous glucose production ď‚Ż
ď‚— insulin clearance ď‚Ż
The Journal of Clinical
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
11. Clinical features
MILD HYPOGLYCEMIA
- mainly adrenergic or cholinergic symptoms
ď‚— Pallor
ď‚— Diaphoresis
ď‚— Tachycardia
ď‚— Palpitations
ď‚— Hunger
ď‚— Paresthesias The Journal of Clinical
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
12. Clinical features
MODERATE HYPOGLYCEMIA (<40 mg/dL)
- mainly neuroglycopenic symptoms
ď‚— Inability to concentrate ď‚· Confusion
ď‚— Slurred speech ď‚· Irrational behaviour
ď‚— Slower reaction time ď‚· Blurred vision
ď‚— Somnolence ď‚· Extreme fatigue
The Journal of Clinical
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
13. Clinical features
SEVERE HYPOGLYCEMIA (<20 mg/dL )
ď‚— Associated with severe impairment of neurologic
function
ď‚— Completely disoriented behavior
ď‚— LOC
ď‚— Coma
ď‚— Seizures
The Journal of Clinical
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
14. Treatment
MILD HYPOGLYCEMIA
ď‚— Oral carbohydrates (at least 15gm)
ď‚— Sources include
• Three glucose tablets (5g each)
• 2 ½ cups of fruit juice
• ½ to ¾ cup regular soda
• 1 cup of milk
ď‚— If patient is unable to take orallyThe Journal of Clinical
give IV dextrose
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
15. Treatment
MODERATE TO SEVERE HYPOGLYCEMIA
ď‚— Dextrose - 50mL of 50% dextrose IV bolus after
blood draw followed by 10% dextrose
 Glucagon – 1mg IM or SC can be given
ď‚— Effective in treating hypoglycemia only if sufficient
liver glycogen present
ď‚— These measures raise blood glucose only transiently
ď‚— Patient is urged to eat as soon as possible
The Journal of Clinical
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
16. Prevention
ď‚— Patient education
ď‚— Knowing signs and symptoms of hypoglycemia
ď‚— Take meals on a regular schedule
ď‚— Carry a source of carbohydrate
ď‚— Self monitoring of blood glucose
ď‚— Take regular insulin at least 30 min before eating
The Journal of Clinical
Endocrinology & Metabolism
March 1, 2009 vol. 94 no. 3 709-
18. ď‚— Acute, major, life-threatening complication of
diabetes
ď‚— Increase in the serum concentration of ketones
ď‚— Blood glucose level of greater than 250 mg/dL
ď‚— Blood pH of less than 7.2
ď‚— Bicarbonate level of 18 mEq/L or less
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
19. ď‚— Incidence about 1 out of 2000
ď‚— Usually occurs in younger individuals but can occur
in patients with diabetes at any age
ď‚— Mortality rates are around 2-5%
ď‚— No sex predilection
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
20. Mechanism
ď‚— Absolute or relative insulin deficiency
ď‚— Increased gluconeogenesis
ď‚— Elevation of counter regulatory hormones such as
glucagon, cortisol, growth hormone, and
catecholamines
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
21. Causes
• Infections
• Inadequate insulin treatment or non-compliance
• New onset diabetes
• Infarction
• Drugs
• Pregnancy
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
22. Classification
Moderate
Mild DKA Severe DKA
DKA
Plasma glucose > 250 mg/dl > 250 mg/dl > 250 mg/dl
Arterial ph 7.25-7.30 7.0-7.24 < 7.0
Serum
15-18 10-<15 < 10
bicarbonate
Urine ketones + + +
Anion gap >10 >12 >12
Alteration in
Joint British Diabetes Society guideline for the
alert Alert/drowsy stupor/coma
sensorium
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
23. Clinical presentations
• Nausea/vomiting  Thirst/polyuria
• Abdominal pain  Shortness of breath
• Generalized weakness  Malaise/lethargy
• Confusional state
• Fever, dysuria, coughing
• Chest pain
• Palpitations
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
24. Physical findings
ď‚— Tachycardia
ď‚— Signs of dehydration - weak and rapid pulse, dry
tongue and skin, hypotension, and increased
capillary refill time
ď‚— Tachypnea/ respiratory distress
ď‚— Acetone odor in breath
ď‚— Abdominal tenderness
ď‚— Lethargy/ obtundation/ cerebral edema/ possibly
coma Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
 Fever/ Hypothermia 28, Issue 5, pages 508–515, May
Medicine Volume
25. Laboratory findings
ď‚— Hyperglycemia >250mg/dL
ď‚— Serum ketones +
ď‚— ABG:
ď‚— metabolic acidosis
ď‚— low bicarbonate
ď‚— low pH (<7.2)
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
26. Serum electrolytes
• Serum potassium may be mildly elevated despite
total body potassium deficit
• The serum sodium level usually is low (1.6meq
reduction in serum sodium for each 5.6mmol/L or
100mg/dL of rise in serum glucose)
• The serum chloride and phosphorus levels are low
ď‚— The anion gap is elevated
ď‚— Plasma osmolarity usually is increased (>290
mOsm/L).Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
27. Others
ď‚— Leukocytosis (even without infection)
ď‚— BUN and creatinine are frequently increased
ď‚— Hypertriglyceridemia/ Hyperlipoproteinemia
 Serum assays for β hydroxybutrate more accurately
reflects the true ketone body level
• ECG – for detection of hypokalemia/ hyperkalemia,
myocardial infarction (silent MI in diabetics)
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
28. Differential diagnosis
LACTIC ACIDOSIS
ď‚— most common cause of metabolic acidosis in
hospitalized patients
ď‚— presentation is identical to DKA
ď‚— serum glucose and ketones should be normal
ď‚— serum lactate concentration should be greater than
5mm
ď‚— therapy is directed at the underlying cause and
optimizing tissue perfusion Society guideline for the
Joint British Diabetes
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
29. Differential diagnosis
STARVATION KETOSIS
ď‚— due to inadequate carbohydrate availability, resulting
in lipolysis and ketone production
ď‚— blood glucose is usually normal
ď‚— blood rarely does have large amounts of ketones
ď‚— arterial pH is normal
ď‚— anion gap is at most mildly elevated
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
30. Differential diagnosis
ALCOHOLIC KETOACIDOSIS
• anion gap is elevated
• serum and urine ketones are present
• alcoholic ketoacidosis produces an even higher ratio
of β-hydroxybutyrate to acetoacetate than DKA does
• usually, patient is normoglycemic or hypoglycemic
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
31. Differential diagnosis
UREMIC ACIDOSIS
ď‚— Extremely large elevations in the BUN (>200 mg/dL)
and creatinine (>10 mg/dL) with normoglycemia
ď‚— pH and anion gap are usually only mildly abnormal
ď‚— treatment is supportive, with careful attention to fluid
and electrolytes until dialysis can be performed
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
32. Treatment
IV FLUIDS
• 2-3L of 0.9% saline over first 1–3 h (10–15mL/kg per
hour)
• 0.45% saline at 150-300mL/h (if hemodynamically
stable and urine output is adequate )
• change to 5% glucose and 0.45% saline at 100–200
mL/h when plasma glucose reaches 250mg/dL
(14mmol/L).
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
33. Treatment
INSULIN
• if serum K+ is <3.3mmol/L, do not administer insulin
until it is corrected to >3.3mmol/L
• bolus of IV (0.1 units/kg) or IM (0.3 units/kg) short-
acting insulin followed by 0.1 units/kg/hr by
continuous IV infusion
• Increase 2- to 3-fold if no response by 2–4h
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
34. Treatment
INSULIN
• IV regular insulin should be given until the acidosis
resolves and the patient is metabolically stable
• Intermediate or long-acting insulin, in combination
with SC short-acting insulin, should be administered
as soon as the patient resumes eating
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
35. Treatment
MONITOR
 Blood glucose every 1–2 h;
ď‚— Serum electrolytes and anion gap every 4 h for first
24 h.
ď‚— Blood pressure, pulse, respirations, mental
status, fluid intake and output every 1–4 h.
Joint British Diabetes Society guideline for the
management of diabetic ketoacidosis Diabetic
Medicine Volume 28, Issue 5, pages 508–515, May
37. ď‚— The condition is characterized by
• Hyperglycemia
• Hyperosmolarity
• Dehydration without significant ketoacidosis
10.2337/diacare.27.2007.S94
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
s102
38. ď‚— Incidence is 1.7 case per 10000
ď‚— Mortality rate is high (10-20%) and usually due to a
co-morbid illness
ď‚— (HHS) has a mean age of onset early in the seventh
decade
10.2337/diacare.27.2007.S94
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
s102
39. Pathophysiology
ď‚— Relative insulin deficiency and inadequate fluid
intake
ď‚— Insulin deficiency increases hepatic glucose
production (through glycogenolysis and
gluconeogenesis) and impairs glucose utilization in
skeletal muscle
ď‚— Hyperglycemia induces an osmotic diuresis that
leads to intravascular volume depletion, which is
exacerbated by inadequate fluid replacement
10.2337/diacare.27.2007.S94
ď‚— Lower levels of counterregulatory hormones and free
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
fatty acids have been found in HHS than in DKA
s102
40. Clinical features
HISTORY
ď‚— Usually elderly individual, type 2 DM
ď‚— Mental confusion, lethargy, and coma
ď‚— Absence of nausea, vomiting, abdominal pain
 Frequent precipitants – pneumonia, sepsis, stroke
MI, etc.,
10.2337/diacare.27.2007.S94
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
s102
41. vs DKA
10.2337/diacare.27.2007.S94
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
s102
42. Treatment
IV FLUIDS
 1–3L of 0.9% normal saline over the first 2–3 h. If the
serum sodium >150 meq/L, 0.45% saline should be
used.
ď‚— After hemodynamic stability is achieved, the IV fluid
administration is directed at reversing the free water
deficit using hypotonic fluids (0.45% saline initially
then D5W).
 The calculated free water deficit (which averages 9–
10.2337/diacare.27.2007.S94
10L) should be reversed over the next 1–2 days
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
(infusion rates of 200–300 mL/h of hypotonic
s102
43. Treatment
INSULIN
• IV insulin bolus of 0.1units/kg followed by IV insulin
at a constant infusion rate of 0.1units/kg per hour.
• If the serum glucose does not fall, increase the
insulin infusion rate by twofold
• Glucose should be added to IV fluid when the
plasma glucose falls to 250 mg/dL, and the insulin
infusion rate should be decreased to 0.05–
0.1units/kg per hour.
10.2337/diacare.27.2007.S94
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
s102
44. Treatment
INSULIN
ď‚— The insulin infusion should be continued until the
patient has resumed eating and can be transferred
to a SC insulin regimen
ď‚— To avoid cerebral edema the blood glucose level
should be maintained between 250-300mg/dl until
hyperosmolarity and mental status improve and the
patient becomes clinically stable
10.2337/diacare.27.2007.S94
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
s102
45. Treatment
POTASSIUM REPLETION
ď‚— ECG monitoring for hyperkalemia or hypokalemia
ď‚— If K+ < 5.5 give 10-20mEq/hr
ď‚— If K+ < 3.5 give 40-80mEq/hr
ď‚— Administer half as chloride and half as phosphate
salts
10.2337/diacare.27.2007.S94
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
s102
46. Monitoring
ď‚— EKG
ď‚— Vital signs
ď‚— 1-2 hourly glucose
ď‚— Serum electrolytes: 2-6 hourly
ď‚— BUN and creatinine: 6-24 hourly
ď‚— Ketones: 6-24 hourly
10.2337/diacare.27.2007.S94
Diabetes Care January 2004vol. 27 no. suppl 1 s94-
s102
47. Pathogenesis of DKA and HHS:
stress, infection, or insufficient insulin. FFA, free fatty acid
48. Conclusion
• Diabetic emergencies are common in patients with
diabetes, and the effects can be devastating.
However, with continued emphasis on the timely
and appropriate identification and management of
diabetic emergencies, hopefully this may change.
• It is therefore important for those with diabetes to
keep their sugar levels normal to prevent
complications and to be able to live normal, healthy
lives.
Hinweis der Redaktion
The universal symbol for diabetes.The purpose of the diabetes symbol is to give diabetes a common identity.Until 2006, there was no global symbol for diabetes. It aims to:support all existing efforts to raise awareness about diabetesinspire new activities, bring diabetes to the attention of the general publicbrand diabetesprovide a means to show support for the fight against diabetes
Insulin doses are excessive, ill-timed, or of the wrong type influx of exogenous glucose (overnight fast or following missed meals or snacks)↑ insulin-independent glucose utilization (e.g., during exercise)↑ sensitivity to insulin (e.g., with improved glycemic control, in the middle of the night, late after exercise, or with increased fitness or weight loss)  endogenous glucose production (e.g., following alcohol ingestion) insulin clearance (e.g., in renal failure).
The anion gap is elevated ([Na + K] - [Cl + HCO3] >13 mEq/L).Plasma osmolarity usually is increased (>290 mOsm/L). If plasma osmolarity cannot be directly measured, it may be calculated as followsPlasma osmolarity = 2 (Na + K) + BUN/3 + glucose/18.